1rtk

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|PDB= 1rtk |SIZE=350|CAPTION= <scene name='initialview01'>1rtk</scene>, resolution 2.30&Aring;
|PDB= 1rtk |SIZE=350|CAPTION= <scene name='initialview01'>1rtk</scene>, resolution 2.30&Aring;
|SITE=
|SITE=
-
|LIGAND= <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene> and <scene name='pdbligand=GBS:4-GUANIDINOBENZOIC ACID'>GBS</scene>
+
|LIGAND= <scene name='pdbligand=GBS:4-GUANIDINOBENZOIC+ACID'>GBS</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>
-
|ACTIVITY= [http://en.wikipedia.org/wiki/Alternative-complement-pathway_C3/C5_convertase Alternative-complement-pathway C3/C5 convertase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.47 3.4.21.47]
+
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Alternative-complement-pathway_C3/C5_convertase Alternative-complement-pathway C3/C5 convertase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.47 3.4.21.47] </span>
|GENE= BF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
|GENE= BF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
 +
|DOMAIN=
 +
|RELATEDENTRY=[[1rrk|1RRK]], [[1rs0|1RS0]]
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1rtk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1rtk OCA], [http://www.ebi.ac.uk/pdbsum/1rtk PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1rtk RCSB]</span>
}}
}}
Line 16: Line 19:
==Disease==
==Disease==
-
Known diseases associated with this structure: Macular degeneration, age-related, reduced risk of OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=138470 138470]]
+
Known disease associated with this structure: Macular degeneration, age-related, reduced risk of OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=138470 138470]]
==About this Structure==
==About this Structure==
Line 32: Line 35:
[[Category: Volanakis, J E.]]
[[Category: Volanakis, J E.]]
[[Category: Xu, Y.]]
[[Category: Xu, Y.]]
-
[[Category: GBS]]
 
-
[[Category: IOD]]
 
-
[[Category: MG]]
 
-
[[Category: NA]]
 
[[Category: bb]]
[[Category: bb]]
[[Category: factor b]]
[[Category: factor b]]
[[Category: factor bb-inhibitor complex]]
[[Category: factor bb-inhibitor complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 13:56:03 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 23:32:47 2008''

Revision as of 20:32, 30 March 2008


PDB ID 1rtk

Drag the structure with the mouse to rotate
, resolution 2.30Å
Ligands: , , ,
Gene: BF (Homo sapiens)
Activity: Alternative-complement-pathway C3/C5 convertase, with EC number 3.4.21.47
Related: 1RRK, 1RS0


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



Crystal Structure Analysis of the Bb segment of Factor B complexed with 4-guanidinobenzoic acid


Contents

Overview

The C-terminal fragment, Bb, of factor B combines with C3b to form the pivotal C3-convertase, C3bBb, of alternative complement pathway. Bb consists of a von Willebrand factor type A (vWFA) domain that is structurally similar to the I domains of integrins and a serine protease (SP) domain that is in inactive conformation. The structure of the C3bBb complex would be important in deciphering the activation mechanism of the SP domain. However, C3bBb is labile and not amenable to X-ray diffraction studies. We engineered a disulfide bond in the vWFA domain of Bb homologous to that shown to lock I domains in active conformation. The crystal structures of Bb(C428-C435) and its inhibitor complexes reveal that the adoption of the "active" conformation by the vWFA domain is not sufficient to activate the C3-convertase catalytic apparatus and also provide insights into the possible mode of C3-convertase activation.

Disease

Known disease associated with this structure: Macular degeneration, age-related, reduced risk of OMIM:[138470]

About this Structure

1RTK is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase., Ponnuraj K, Xu Y, Macon K, Moore D, Volanakis JE, Narayana SV, Mol Cell. 2004 Apr 9;14(1):17-28. PMID:15068800

Page seeded by OCA on Sun Mar 30 23:32:47 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools